HealthElevate provides structured Decision Instruments for executives facing high-stakes, difficult-to-reverse choices — before those choices become irreversible.
We are not a consulting firm, an analytics vendor, or an AI company. HealthElevate operates above vendors and below boards — providing independent analytical judgment through proprietary Decision Instruments when it matters most.
Eleven proprietary instruments across VBHC readiness, AI governance, population health, revenue sustainability, regulatory preparedness, and more — each designed to deliver a clear proceed, delay, or redesign recommendation.
Every engagement is grounded in publicly available data only — vendor-neutral, COI-protected, and designed to withstand board-level scrutiny. Our independence is the value.
Every engagement concludes with a structured written brief: section-by-section risk analysis, an explicit Proceed / Delay / Redesign recommendation, and a summary ready for executive or board presentation.
Engagements are structured around specific decision contexts — not open-ended retainers. Each tier delivers a defined instrument output with a clear scope and timeline.
A focused 90-minute structured diagnostic for a single high-priority decision. Ideal for a specific readiness check, governance review, or pre-contract stress test.
A comprehensive multi-instrument assessment with a full written report and a 60-minute executive briefing session. The primary engagement tier for major transformation decisions.
Three coordinated Full Diagnostics across a transformation programme, with 90 days of retained advisory access. Designed for health systems managing multiple parallel decisions.
Each instrument addresses a specific high-stakes healthcare decision. Our methodology — Instrument-Led, Evidence-Backed — ensures structured rigour at every stage of the decision lifecycle.
"Are we operationally and financially ready to enter a value-based contract?"
"Is our AI system safe, explainable, and decision-ready before we scale?"
"Are we ready to launch or scale a population health management programme?"
"Is our revenue model resilient under payer tightening?"
"Is our organisation capable of integrated care decision-making?"
"Are we structurally exposed to fraud, waste, and abuse — even if none has been detected?"
"Are we losing more money to bad denials than to fraud itself?"
"Can this digital solution safely scale beyond the pilot phase?"
"How exposed are we to regulatory reinterpretation or enforcement tightening?"
"Is the board being asked to approve something irreversible without sufficient assurance?"
"Can this organisation absorb change without destabilising care delivery?"
HealthElevate is designed for healthcare leaders who carry decision responsibility — not those who study it from a distance.
Revenue resilience, VBHC contract risk, denial exposure, and cash-flow stress testing under payment reform.
Change-readiness, integrated care capability, digital health scale-up risk, and population health programme launches.
AI deployment governance, clinical decision safety, FWA structural exposure, and care pathway integrity.
Contract stress testing, readiness sequencing, failure-mode identification, and regulatory shock scenarios.
Board-level decision safety reviews, irreversibility assessments, and governance gate approvals for major commitments.
System-level analytical work aligned to Vision 2030, CNHI capitation reform, NPHIES integration, and PHM programme scale-up.
HealthElevate Ltd is an independent healthcare analytics company incorporated in England and Wales (Company No. 16913517), operating at the intersection of Saudi Arabia's Vision 2030 healthcare transformation and the analytical disciplines required to navigate it with confidence.
Our founder brings deep operational expertise from inside the Saudi healthcare payer system — including claims management, NPHIES operations, population health management, and value-based contracting — combined with the professional independence required to deliver objective diagnostic work.
We exist to serve one function: ensuring that the decisions shaping healthcare systems are made with the rigour they deserve. Not after the contract is signed. Before.
HealthElevate is registered in London, UK. All analytical work is conducted from publicly available data sources only, in strict accordance with our published conflict-of-interest framework. Our scope deliberately excludes implementation, vendor support, and regulatory navigation.
Every engagement begins with a focused conversation about your specific decision context. No open-ended retainers. No jargon. Structured analytical support, precisely scoped.
Start a Conversation